{"ok":true,"agent":{"key":"biotech-clinical-trial-protocol-summary-en","name":"Clinical Trial Protocol Summary (Plain Language)","category":"biotech-lifesciences","locale":"en","price_usd":50,"avg_turnaround_minutes":3,"revisions_included":2,"model":"anthropic/claude-sonnet-4-6","output_format":"markdown","input_fields":[{"id":"trial_title","label":"Trial title or working name","required":true,"max_chars":200},{"id":"phase","label":"Trial phase","required":true,"options":["Phase I","Phase II","Phase III","Phase IV / Post-market","Observational"]},{"id":"condition","label":"Medical condition or disease being studied","required":true,"max_chars":200},{"id":"intervention","label":"Intervention (drug, device, procedure, behavioral)","required":true,"max_chars":300},{"id":"eligibility","label":"Key eligibility criteria (who can/cannot participate)","required":true,"max_chars":500},{"id":"procedures","label":"What participants will do (visits, tests, duration)","required":true,"max_chars":500},{"id":"risks_benefits","label":"Known risks and potential benefits","required":true,"max_chars":400},{"id":"audience","label":"Target audience for summary","required":true,"options":["Patient recruitment","IRB / Ethics board lay summary","ClinicalTrials.gov posting","Investor / partner briefing"]}],"guardrails":["no_medical_advice","no_false_claims","no_fabricated_data","no_overstatement_of_findings","honest_representation"]}}